Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02534181Phase 2Withdrawn
Phase 2, randomised, open-label trial in Refeeding syndrome (RFS) (2 arms), sponsored by Universidade de São Paulo. Primary endpoint: Logistic Organ Dysfunction Score at 72 hours. Planned start Jul 2015; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02534181.